Table 3.
Resistance pattern of vaginal E. coli isolates to antibacterial agents
|
Antibacterial agent* |
% of Resistant isolates |
|||||
|---|---|---|---|---|---|---|
|
Pregnant women's isolates |
Non-pregnant women's isolates |
All isolates |
||||
| Total (n = 19) | ESBL+ (n = 14) | Total (n = 32) | ESBL+ (n = 18) | Total (n = 51) | ESBL+ (n = 32) | |
| Gentamicin |
36.8 |
50.0 |
18.75 |
27.7 |
25.4 |
37.5 |
| Kanamicin |
26.3 |
35.7 |
43.7 |
50.0 |
37.2 |
43.7 |
| Ciprofloxacin |
31.5 |
42.8 |
28.1 |
38.8 |
29.4 |
40.6 |
| Norfloxacin |
26.3 |
35.7 |
21.8 |
27.7 |
(21.5 |
31.2 |
| Trimethoprim-sulfamethoxazole |
31.5 |
42.8 |
53.1 |
72.2 |
45.0 |
59.3 |
| Meropenem |
0 |
0 |
0 |
0 |
0 |
0 |
| Imipenem |
0 |
0 |
0 |
0 |
0 |
0 |
| Amoxicillin-clavulanic acid |
100 |
100 |
100 |
100 |
100 |
100 |
| Cefotaxime |
100 |
100 |
78.1 |
91.3 |
86.2 |
93.7 |
| Ceftazidime |
57.8 |
76.4 |
71.8 |
78.2 |
66.6 |
81.2 |
| Ceftriaxone |
42.1 |
57.1 |
46.8 |
61.1 |
45.0 |
59.3 |
| Aztreonam |
42.1 |
57.1 |
46.8 |
61.1 |
45.0 |
59.3 |
| % Multidrug resistance | 36.8 | 50.0 | 50.0 | 61.1 | 45.0 | 56.2 |
* For all the tested antibiotics (tested later in the study), the total number of isolates was 51 (10 isolates were lost during storage as a result of electricity instability), except for cefotaxime and ceftazidime (tested early during the study) the number of isolates was 61.